US 9090630
Macrocyclic FLT3 kinase inhibitors
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 9090630 (Macrocyclic FLT3 kinase inhibitors) held by Oncodesign SA expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61P, A61P35/00